Cytarabine

ब्रांड नाम

Nepal brand names not included: no licence-safe source.

What it is used for

Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of Cytarabine Injection is indicated in the prophylaxis and treatment of meningeal leukemia.

Common side effects

Expected Reactions Because cytarabine is a bone marrow suppressant, anemia, leukopenia, thrombocytopenia, megaloblastosis and reduced reticulocytes can be expected as a result of administration with cytarabine. Cellular changes in the morphology of bone marrow and peripheral smears can be expected.

Do not use if (contraindications)

Cytarabine is contraindicated in those patients who are hypersensitive to the drug.

Pregnancy & breastfeeding

Pregnancy (label summary): See WARNINGS. A review of the literature has shown 32 reported cases where cytarabine was given during pregnancy, either alone or in combination with other cytotoxic agents. Eighteen normal infants were delivered. Four of these had first trimester exposure. Breastfeeding (label summary): Nursing mothers It is not known whether this drug is excreted in human milk.

सामान्य प्रश्न

What is Cytarabine used for?
Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia.

What are the side effects of Cytarabine?
Expected Reactions Because cytarabine is a bone marrow suppressant, anemia, leukopenia, thrombocytopenia, megaloblastosis and reduced reticulocytes can be expected as a result of administration with cytarabine. Cellular changes in the morphology of bone marrow and peripheral smears can be expected.

Who should not take Cytarabine?
Cytarabine is contraindicated in those patients who are hypersensitive to the drug.

Does Cytarabine have a boxed warning?
Only physicians experienced in cancer chemotherapy should use cytarabine. For induction therapy patients should be treated in a facility with laboratory and supportive resources sufficient to monitor drug tolerance and protect and maintain a patient compromised by drug toxicity.

Can I take Cytarabine in pregnancy or while breastfeeding?
Pregnancy (label summary): See WARNINGS. A review of the literature has shown 32 reported cases where cytarabine was given during pregnancy, either alone or in combination with other cytotoxic agents. Eighteen normal infants were delivered. Four of these had first trimester exposure.

What is the dose of Cytarabine?
Not provided here. Ask a doctor or pharmacist.

Cytarabine क्या है?
Cytarabine is used for: Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It belongs to the class: Nucleoside Metabolic Inhibitor. Common side effects include: Expected Reactions Because cytarabine i…

Cytarabine के दुष्प्रभाव क्या हैं?
Expected Reactions Because cytarabine is a bone marrow suppressant, anemia, leukopenia, thrombocytopenia, megaloblastosis and reduced reticulocytes can be expected as a result of administration with cytarabine. Cellular changes in the morphology of bone marrow and peripheral smears can be expected.